ABBOTT ROLLING OUT LCx CHLAMYDIA TEST IN U.S. FOLLOWING 510(K) CLEARANCE; CORPORATE SALES HIT $10 BIL. IN 1995, UP 9.6%; HOSPITAL/LAB SALES GAIN 4.6%
This article was originally published in The Gray Sheet
Executive Summary
Abbott Laboratories is launching its LCx gene amplification test for chlamydia following receipt of 510(k) clearance from FDA on Dec. 8. The urine-based test is the first semi-automated gene amplification test to reach the U.S. market.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.